Prospective surveillance of invasive group A streptococcal disease, fiji, 2005-2007

Emerging Infectious Diseases

Volumn 15, Issue 2, 2009, Pages 216-222

  Steer, Andrew C ^a   Jenney, Adam ^a   Kado, Joseph ^b   Good, Michael F ^c   Batzloff, Michael ^c   Waqatakirewa, Lepani ^b   Mullholland, E Kim ^a,d   Carapetis, Jonathan R ^a,e  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b Ministry of Health   (Fiji)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CASE FINDING; CHILD; CLINICAL FEATURE; COMORBIDITY; DIABETES MELLITUS; FATALITY; FEMALE; FIJI; GROUP A STREPTOCOCCAL INFECTION; GROUPS BY AGE; HEALTH SURVEY; HUMAN; INCIDENCE; INFANT; INFECTION RATE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PROSPECTIVE STUDY; SCHOOL CHILD; SEROTYPING;

EID: 63849156638     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid15/2.080558     Document Type: Article

References (32)

1. SR1. Steer AC, Curtis N, Carapetis JR. Diagnosis and treatment of invasive group A streptococcal infections. Expert Opinion in Medical Diagnostics. 2007;2:289-302. DOI: 10.1517/17530059.2.3.289
2. Hoge CW, Schwartz B, Talkington DF, Breiman RF, MacNeill EM, Englender SJ. The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. A retrospective population-based study. JAMA. 1993;269:384-9. DOI: 10.1001/jama.269.3.384
3. Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis. 2005;5:685-94. DOI: 10.1016/S1473-3099(05)70267-X
4. Lamagni TL, Duckworth G, Emery M, Tanna A, George RC, Ef- stratiou A. The changing epidemiology of invasive Streptococcus pyogenes infections in England and Wales: 1991-2001. 15th Lance- field International Symposium on Streptococci and Streptococcal Diseases; 2002; Goa, India. p. O1.4.
5. Lamagni TL, Efstratiou A, Vuopio-Varkila J, Jasir A, Schalen C. Strep-EURO. The epidemiology of severe Streptococcus pyogenes associated disease in Europe. Euro Surveill. 2005;10:179-84.
6. O'Brien KL, Beall B, Barrett L, Cieslak PR, Reingold A, Farley MM, et al. Epidemiology of invasive group A streptococcus disease in the United States, 1995-1999. Clin Infect Dis. 2002;35:268-76. DOI: 10.1086/341409
7. Li Z, Sakota V, Jackson D, Franklin AR, Beall B. Array of protein gene subtypes in 1064 recent invasive group A streptococcus isolates recovered from the Active Bacterial Core Surveillance. J Infect Dis. 2003;188:1587-92. DOI: 10.1086/379050
8. O'Loughlin RE, Roberson A, Cieslak PR, Lynfield R, Gershman K, Craig A, et al. The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004. Clin Infect Dis. 2007;45:853-62. DOI: 10.1086/521264
9. Steer AC, Jenney AJ, Oppedisano F, Batzloff MR, Hartas J, Pass- more J, et al. High burden of invasive beta-haemolytic streptococcal infections in Fiji. Epidemiol Infect. 2008;136:621-7. DOI: 10.1017/ S095026880700917X
10. Statistical News Press Release No. 52. Suva (Fiji): Fiji Islands Bureau of Statistics; October 31, 2007.
11. Human Development Report 2006: United Nations Development Programme. New York: Palgrave Macmillan; 2006.
12. Fiji facts and figures as of July 2007. Suva (Fiji): Fiji Islands Bureau of Statistics; 2007.
13. Howard A, Rensel J. Island legacy: a history of the Rotuman people, 1st ed. Victoria (Canada): Trafford Publishing; 2007.
14. Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. The Working Group on Severe Streptococcal Infections. JAMA. 1993;269:390-1. DOI: 10.1001/jama.269.3.390
15. Beall B, Facklam R, Thompson T. Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. J Clin Microbiol. 1996;34:953-8.
16. Berkley JA, Lowe BS, Mwangi I, Williams T, Bauni E, Mwarumba S, et al. Bacteremia among children admitted to a rural hospital in Kenya. N Engl J Med. 2005;3 52:39-47. DOI: 10.1056/NEJ-Moa040275
17. Norton R, Smith HV, Wood N, Siegbrecht E, Ross A, Ketheesan N. Invasive group A streptococcal disease in North Queensland (1996-2001). Indian J Med Res. 2004;119(Suppl):148-51.
18. Carapetis JR, Walker AM, Hibble M, Sriprakash KS, Currie BJ. Clinical and epidemiological features of group A streptococcal bacteraemia in a region with hyperendemic superficial streptococcal infection. Epidemiol Infect. 1999;122:59-65. DOI: 10.1017/S0950268898001952
19. Zimmet P, Taylor R, Ram P, King H, Sloman G, Raper LR, et al. Prevalence of diabetes and impaired glucose tolerance in the biracial (Melanesian and Indian) population of Fiji: a rural-urban comparison. Am J Epidemiol. 1983;118:673-88.
20. Collins VR, Dowse GK, Cabealawa S, Ram P, Zimmet P. High mortality from cardiovascular disease and analysis of risk factors in Indian and Melanesian Fijians. Int J Epidemiol. 1996;25:59-69. DOI: 10.1093/ije/25.1.59
21. Finger F, Rossaak M, Umstaetter R, Reulbach U, Pitto R. Skin infections of the limbs of Polynesian children. N Z Med J. 2004;117:U847.
22. Tiu A, Martin R, Vanniasingham P, MacCormick AD, Hill AG. Necrotizing fasciitis: analysis of 48 cases in South Auckland, New Zealand. ANZ J Surg. 2005;75:32-4. DOI: 10.1111/j.1445-2197.2005.03289.x
23. O'Grady K-A, Kelpie L, Andrews RA, Curtis N, Nolan TM, Sel-varaj G, et al. The epidemiology of invasive group A streptococcal disease in Victoria, Australia. Med J Aust. 2007;186:565-9.
24. Zurawski CA, Bardsley M, Beall B, Elliott JA, Facklam R, Schwartz B, et al. Invasive group A streptococcal disease in metropolitan Atlanta: a population-based assessment. Clin Infect Dis. 1998;27:150-7. DOI: 10.1086/514632
25. Tyrrell GJ, Lovgren M, Kress B, Grimsrud K. Invasive group A streptococcal disease in Alberta, Canada (2000-2002). J Clin Micro- biol. 2005;43:1678-83. DOI: 10.1128/JCM.43.4.1678-1683.2005
26. Eriksson BK, Andersson J, Holm SE, Norgren M. Epidemiologi- cal and clinical aspects of invasive group A streptococcal infections and the streptococcal toxic shock syndrome. Clin Infect Dis. 1998;27:1428-36. DOI: 10.1086/515012
27. Bessen DE, Carapetis JR, Beall B, Katz R, Hibble M, Currie BJ, et al. Contrasting molecular epidemiology of group A streptococci causing tropical and nontropical infections of the skin and throat. J Infect Dis. 2000;182:1109-16. DOI: 10.1086/315842
28. Wagner JG, Schlievert PM, Assimacopoulos AP, Stoehr JA, Carson PJ, Komadina K. Acute group G streptococcal myositis associated with streptococcal toxic shock syndrome: case report and review. Clin Infect Dis. 1996;23:1159-61.
29. Sharma M, Khatib R, Fakih M. Clinical characteristics of necro- tizing fasciitis caused by group G Streptococcus: case report and review of the literature. Scand J Infect Dis. 2002;34:468-71. DOI: 10.1080/003655402320170318
30. Bisno AL, Rubin FA, Cleary PP, Dale JB. Prospects for a group A streptococcal vaccine: rationale, feasibility, and obstacles-report of a National Institute of Allergy and Infectious Diseases workshop. Clin Infect Dis. 2005;41:1150-6. DOI: 10.1086/444505
31. Kotloff KL, Corretti M, Palmer K, Campbell JD, Reddish MA, Hu MC, et al. Safety and immunogenicity of a recombinant multivalent group a streptococcal vaccine in healthy adults: phase 1 trial. JAMA. 2004;292:709-15. DOI: 10.1001/jama.292.6.709
32. McNeil SA, Halperin SA, Langley JM, Smith B, Warren A, Sharratt GP, et al. Safety and immunogenicity of 26-valent group A streptococcus vaccine in healthy adult volunteers. Clin Infect Dis. 2005;41:1114-22. DOI: 10.1086/444458